Skip to main content
DreamCIS INC. logo

DreamCIS INC. — Investor Relations & Filings

Ticker · 223250 ISIN · KR7223250002 KO Professional, scientific and technical activities
Open in API
Filings indexed 200 across all filing types
Latest filing 2021-03-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 223250

About DreamCIS INC.

https://dreamcis.com/

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to directors and employees, including exercise price, vesting periods, and valuation methodology. In the context of Korean corporate filings (DART system), this is a specific regulatory disclosure regarding capital/share-based compensation changes. Since it does not fit into 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes), and is a specific regulatory requirement for stock option grants, it falls under the 'Regulatory Filings' category as the most appropriate fallback for this type of corporate disclosure.
2021-03-26 Korean
사업보고서 (2020.12)
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for DreamCIS for the fiscal year 2020. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. Since it contains full financial statements and audit results for a specific fiscal period, it is classified as an Interim/Quarterly Report (IR) in the context of this classification system, as it represents the full annual financial reporting package. FY 2020
2021-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) from DreamCIS. It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit), and auditor information. While it contains financial data, it is a regulatory disclosure announcement summarizing the audit results rather than the full, multi-page audited financial statement document itself. According to the 'Menu vs Meal' rule, this is an announcement of the report's submission, fitting the criteria for a Report Publication Announcement. FY 2020
2021-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for DreamCIS. It contains the meeting agenda, details on voting rights, director activities, and business overview. This type of document is a standard proxy statement/information circular provided to shareholders to solicit votes and inform them of the upcoming AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for DreamCIS. It outlines the date, location, and agenda items (financial statements, board appointments, etc.) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/votes. Given the specific category definitions, this fits best as a Proxy Solicitation & Information Statement (PSI).
2021-03-09 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회 집중일 개최 사유 신고' (Report on the reason for holding a general meeting on a concentrated date). It explains why the company, DreamCIS, is holding its annual general meeting on a date that coincides with other companies' meetings, citing scheduling conflicts with auditors and management. As this is a specific regulatory disclosure regarding meeting logistics and does not fit into the other categories like AGM-R (presentation materials) or PSI (proxy solicitation), it is classified as a general regulatory filing.
2021-03-09 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.